Long-Acting Injectables for HIV Antiretroviral Therapy
Resource updated 04/12/2024
Resource updated 04/12/2024
Resource (Conference Presentation) updated 09/14/2023
Resource updated 12/19/2023
Resource updated 09/19/2023
Resource updated 05/11/2023
Resource updated 04/07/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
The purpose of the ESCALATE training program is to facilitate transformative and relational change in Ryan White HIV/AIDS Programs (RWHAP) and the communities they serve. This is a Glossary of commonly used terms under in the ESCALATE capacity-building initiative.
Resource updated 05/14/2024